Boyke Andre Everett, Michel Michelot, Garcia Catherine Michelle, Bannykh Serguei I, Chan Julie Lynn, Black Keith L
Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, United States.
Department of Neurosurgery, University of Florida College of Medicine, Gainesville, United States.
Surg Neurol Int. 2023 Oct 13;14:364. doi: 10.25259/SNI_599_2023. eCollection 2023.
Meningiomas are the most common primary intracranial tumor with increasing incidence. Stereotactic Radiosurgery Gamma Knife (SRS-GK) is a commonly used modality for neoadjuvant and adjuvant treatment of these tumors and is often necessary for long-term disease control, particularly for the World Health Organization grade II/III meningiomas. While there is strong evidence to support the use of SRS-GK for meningioma, there exists a risk of secondary malignancy that is not well understood. We report a case of glioblastoma (GBM) that arose near the bed of a meningioma previously treated with SRS-GK and discuss other cases of GBM that emerged at a site of meningioma reported in the literature.
A 79-year-old female with a history of a blood-clotting disorder presented to the hospital with sudden facial sensory disturbances. On magnetic resonance imaging (MRI), a homogeneously enhancing lesion was observed in the right temporal lobe, consistent with a meningioma. Following 2 years of surveillance, the patient underwent SRS-GK for enlargement of the lesion. The patient later presented with headache and gait instability 12 years following SRS-GK. MRI revealed a large ring-enhancing lesion with surrounding edema histologically confirmed to be a GBM. At 9 months following initial tumor resection and a combination of radiotherapy and temozolomide, the patient was neurologically intact.
There is a very small risk of meningioma to GBM conversion following SRS. Although SRS-GK poses a risk of secondary malignancy, there are some reported cases that underwent malignant transformation without SRS-GK. This suggests that SRS-GK is not the only factor in transformation and is a reasonable therapeutic modality to consider utilizing. Patients and their families should be appropriately counseled on the potential risks of radiation therapy, even for benign lesions like a meningioma.
脑膜瘤是最常见的原发性颅内肿瘤,发病率呈上升趋势。立体定向放射外科伽玛刀(SRS-GK)是这些肿瘤新辅助和辅助治疗常用的方式,对于长期疾病控制通常是必要的,特别是对于世界卫生组织二级/三级脑膜瘤。虽然有强有力的证据支持使用SRS-GK治疗脑膜瘤,但存在一种尚未完全了解的继发性恶性肿瘤风险。我们报告一例胶质母细胞瘤(GBM)发生在先前接受SRS-GK治疗的脑膜瘤床附近,并讨论文献中报道的在脑膜瘤部位出现的其他GBM病例。
一名有凝血障碍病史的79岁女性因突发面部感觉障碍入院。磁共振成像(MRI)显示右侧颞叶有一个均匀强化的病变,符合脑膜瘤表现。经过2年的观察,患者因病变增大接受了SRS-GK治疗。在SRS-GK治疗12年后,患者出现头痛和步态不稳。MRI显示一个大的环形强化病变,周围有水肿,组织学证实为GBM。在初次肿瘤切除并联合放疗和替莫唑胺治疗9个月后,患者神经功能完好。
SRS治疗后脑膜瘤转化为GBM的风险非常小。虽然SRS-GK有继发性恶性肿瘤的风险,但也有一些报道的病例在未接受SRS-GK的情况下发生了恶性转化。这表明SRS-GK不是转化的唯一因素,是一种值得考虑使用的合理治疗方式。即使对于像脑膜瘤这样的良性病变,也应该向患者及其家属适当告知放疗的潜在风险。